Artivion Inc (AORT) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.

Total Cash From Operating Activities Chart for Artivion Inc

Artivion Inc (AORT) operating cash flow for FY2025 was USD 38.1M, a 71.5% change from FY2024. Artivion Inc's operating cash flow moved from USD -2.3M in 1991 to USD 38.1M in 2025 over 34 years. Operating cash flow compound annual growth rate: 5-year CAGR of 25.3%, 10-year CAGR of 12.8%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$1.14B
Implied Share Price
$23.30
Enterprise Value
$1.49B
Revenue (TTM)
$471.47M
EBITDA
$63.72M
Profit Margin
-0.67%
Trailing P/E
—
Forward P/E
35.97
Price/Book (MRQ)
2.61
Price/Sales (TTM)
2.41
EV/EBITDA
29.28
EV/Revenue
3.17
Dividend Yield
—
Book Value
$9.15
Free Cash Flow (FY2025)
-$911,000.00
Free Cash Flow Yield
-0.08%

Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.